相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells
Tatiana Traboulsi et al.
ONCOGENE (2019)
Isolation and functional characterization of a novel endogenous inverse agonist of estrogen related receptors (ERRs) from human pregnancy urine
Faegheh Ghanbari et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Inhibition of ERRα Prevents Mitochondrial Pyruvate Uptake Exposing NADPH-Generating Pathways as Targetable Vulnerabilities in Breast Cancer
Sunghee Park et al.
CELL REPORTS (2019)
Updating the role of obesity and cholesterol in breast cancer
Laura Garcia-Estevez et al.
BREAST CANCER RESEARCH (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
Ivan Casaburi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Statin drugs to reduce breast cancer recurrence and mortality
Colin H. Beckwitt et al.
BREAST CANCER RESEARCH (2018)
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
Amy E. Baek et al.
NATURE COMMUNICATIONS (2017)
ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism
Adi Y. Berman et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
Subrata Manna et al.
CLINICAL CANCER RESEARCH (2016)
Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects
Wei Wei et al.
CELL METABOLISM (2016)
Diet and risk of breast cancer
Manas Kotepui
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2016)
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
Genevieve Deblois et al.
NATURE COMMUNICATIONS (2016)
ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer
Sunghee Park et al.
CELL REPORTS (2016)
14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells
Tong Li et al.
PLOS ONE (2016)
The effect of statins on cancer cells-review
Lucyna Matusewicz et al.
TUMOR BIOLOGY (2015)
Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis
L. Zeng et al.
ONCOGENE (2015)
Hypercholesterolemia Induces Angiogenesis and Accelerates Growth of Breast Tumors in Vivo
Kristine Pelton et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Obesity, Cholesterol Metabolism, and Breast Cancer Pathogenesis
Donald P. McDonnell et al.
CANCER RESEARCH (2014)
Cholesterol and breast cancer pathophysiology
Erik R. Nelson et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
S. Jiralerspong et al.
ANNALS OF ONCOLOGY (2013)
Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis
Mariaelena Pierobon et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer
Rosalyn D. Ferguson et al.
ENDOCRINE-RELATED CANCER (2013)
Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status
Mark F. Munsell et al.
EPIDEMIOLOGIC REVIEWS (2013)
Lovastatin-induced decrease of intracellular cholesterol level attenuates fibroblast-to-myofibroblast transition in bronchial fibroblasts derived from asthmatic patients
Marta Michalik et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model
N. Alikhani et al.
ONCOGENE (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Targeting cellular metabolism to improve cancer therapeutics
Y. Zhao et al.
CELL DEATH & DISEASE (2013)
Molecular Pathways: The Metabolic Regulator Estrogen-Related Receptor α as a Therapeutic Target in Cancer
Ching-yi Chang et al.
CLINICAL CANCER RESEARCH (2012)
Cholesterol and breast cancer development
Christiane Danilo et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease
Genevieve Deblois et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Lydia W. S. Finley et al.
CANCER CELL (2011)
The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer
Ching-yi Chang et al.
CANCER CELL (2011)
Dual Function of ERRα in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and Osteoprotegerin
Anais Fradet et al.
CANCER RESEARCH (2011)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor α as a Determinant of Breast Cancer Heterogeneity
Genevieve Deblois et al.
CANCER RESEARCH (2009)
Modulating Estrogen Receptor-related Receptor-α Activity Inhibits Cell Proliferation
Stephanie Bianco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The significance of the expression of ERR alpha as a potential biomarker in breast cancer
Katarzyna Jarzabek et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells
Rebecca A. Stein et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Estrogen-related receptor-α antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts
Michael J. Chisarnore et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Estrogen-Related Receptor a Is Critical for the Growth of Estrogen Receptor-Negative Breast Cancer
Rebecca A. Stein et al.
CANCER RESEARCH (2008)
Phosphorylation-dependent sumoylation regulates estrogen-related receptor-α and -γ transcriptional activity through a synergy control motif
Annie M. Tremblay et al.
MOLECULAR ENDOCRINOLOGY (2008)
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Potentiation of ICI182,780 (fulvestrant)-induced estrogen receptor-α degradation by the estrogen receptor-related receptor-α inverse agonist XCT790
Olivia Lanvin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Adaptation of energy metabolism in breast cancer brain metastases
Emily I. Chen et al.
CANCER RESEARCH (2007)
Mitochondria and reactive oxygen species in renal cancer
Eric Hervouet et al.
BIOCHIMIE (2007)
Serum lipids and outcome of early-stage breast cancer: Results of a prospective cohort study
M Bahl et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Estrogen-related receptor a in human breast carcinoma as a potent prognostic factor
T Suzuki et al.
CANCER RESEARCH (2004)
Implementation of the Women's Health Initiative Study Design
GL Anderson et al.
ANNALS OF EPIDEMIOLOGY (2003)
Estrogen-related receptor α1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells
RJ Kraus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)